Thomas Peters Discloses 5.2% Stake in Nuvectis Pharma

TL;DR

**Thomas Peters now owns 5.2% of Nuvectis Pharma, a notable individual stake.**

AI Summary

Thomas Peters, an individual investor, has updated his ownership stake in Nuvectis Pharma, Inc. (NUVB) as of December 31, 2023. He now beneficially owns 908,475 shares, representing 5.2% of the company's common stock. This is an amendment to a previous filing, indicating a change in his holdings or reporting status. This matters to investors because a significant individual stake can signal confidence in the company's future, but also means a large block of shares could be sold, potentially impacting the stock price.

Why It Matters

This filing shows a notable individual investor, Thomas Peters, holds a significant 5.2% stake in Nuvectis Pharma, which can influence investor perception and potentially the stock's liquidity.

Risk Assessment

Risk Level: medium — While a large individual stake can signal confidence, it also means a single person holds significant voting and selling power, which could create volatility.

Analyst Insight

Smart investors should monitor future filings by Thomas Peters for any changes in his ownership, as a significant increase or decrease could signal his evolving confidence in Nuvectis Pharma's prospects.

Key Numbers

• 908,475 — Shares Beneficially Owned (Total shares owned by Thomas Peters in Nuvectis Pharma.)
• 5.2% — Percentage of Class (Thomas Peters' ownership percentage of Nuvectis Pharma's common stock.)
• 17,326,594 — Shares Outstanding (Total shares outstanding used to calculate the ownership percentage, as reported on the Issuer's Form 10-Q.)
• 263,193 — Sole Voting/Dispositive Power (Shares over which Thomas Peters has sole voting and dispositive control.)
• 645,282 — Shared Voting/Dispositive Power (Shares over which Thomas Peters shares voting and dispositive control.)

Key Players & Entities

• Thomas Peters (person) — reporting person and beneficial owner of Nuvectis Pharma shares
• Nuvectis Pharma, Inc. (company) — the issuer of the securities
• 908,475 shares (dollar_amount) — aggregate amount beneficially owned by Thomas Peters
• 5.2% (dollar_amount) — percentage of class represented by Thomas Peters' ownership
• December 31, 2023 (date) — date of event which requires filing of this statement

Forward-Looking Statements

• Thomas Peters will maintain a significant stake in Nuvectis Pharma for the foreseeable future. (Thomas Peters) — medium confidence, target: December 31, 2024
• The stock price of Nuvectis Pharma will not experience significant volatility directly due to this filing in the short term. (Nuvectis Pharma, Inc.) — high confidence, target: March 31, 2024

FAQ

Key Financial Figures

• $0.00001 — me of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securiti

Filing Documents

• tm244636d1_sc13ga.htm (SC 13G/A) — 35KB
• 0001104659-24-008426.txt ( ) — 36KB

(a) & (b). Name and Principal Business

Item 2(a) & (b). Name and Principal Business Offices of Persons Filing: Thomas Peters 7 Rehan Street Evan Yehuda, Israel 4050003

(c). Citizenship

Item 2(c). Citizenship: United States

(d). Title of Class of Securities

Item 2(d). Title of Class of Securities: Common Stock, par value $0.00001 per share

(e). CUSIP Number

Item 2(e). CUSIP Number: 67080T108

If this statement is filed pursuant to

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with §240.13d-1(b)(1)(ii)(K).

Ownership

Item 4. Ownership. (a) Amount beneficially owned: 908,475 (b) Percent of Class: 5.2%* (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 263,193 (ii) shared power to vote or to direct the vote: 645,282 (iii) sole power to dispose or to direct the disposition of: 263,193 (iv) shared power to dispose or to direct the disposition of: 645,282 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following . 6. Ownership of More than Five Percent on Behalf of Another Person. N/A 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. N/A 8. Identification and Classification of Members of the Group. N/A 9. Notice of Dissolution of Group. N/A 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. * Calculated based on 17,326,594 shares outstanding as reported on the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 8, 2023. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 30, 2024 By: /s/ Thomas Peters Date Name: Thomas Peters

View Full Filing

View this SC 13G/A filing on SEC EDGAR